Recommended Laboratory Testing Sequence for Hepatitis C Diagnosis
The recommended laboratory testing sequence for diagnosing hepatitis C (HCV) infection is to order HCV-antibody testing with reflex HCV RNA polymerase chain reaction testing for initial HCV screening. 1
Initial Testing Algorithm
First-line test: HCV antibody test
Interpretation of HCV antibody results:
- Nonreactive: No HCV antibody detected (no current or past infection in most cases)
- Reactive: Indicates one of three possibilities:
- Current HCV infection (acute or chronic)
- Past, resolved HCV infection
- False positive result 1
Reflex testing for reactive antibody results:
- All reactive HCV antibody tests should automatically reflex to HCV RNA testing 1
- HCV RNA testing confirms active infection and distinguishes between current infection and resolved/false positive results
Special Testing Considerations
Recent exposure (within 6 months):
- Consider direct HCV RNA testing or follow-up HCV antibody testing 6+ months after exposure 1
- HCV antibody may not be detectable during this "window period"
Immunocompromised patients:
Persons at risk for reinfection:
- Use HCV RNA testing directly (antibody will remain positive from previous infection) 1
Distinguishing false positives from resolved infection:
Pre-Treatment Testing
If HCV RNA is detected (confirming current infection), additional testing is recommended:
Quantitative HCV RNA testing:
- Documents baseline viral load before starting treatment 1
HCV genotype testing:
- May be considered if it would alter treatment recommendations 1
Additional recommended tests:
- Liver function tests (AST/ALT, alkaline phosphatase, bilirubin, albumin)
- Complete blood count
- Prothrombin time/INR
- Testing for coinfections (HBV, HIV) 2
Common Pitfalls to Avoid
Incomplete testing: Ordering only HCV antibody without reflex to RNA testing leads to diagnostic delays and loss to follow-up 1
Misinterpreting positive antibody tests: A positive antibody test alone doesn't confirm current infection 1
Missing acute infections: Relying solely on antibody testing in recently exposed individuals may miss early infections 1
Inadequate specimen handling: Improper storage or handling of specimens for HCV RNA testing can lead to false negative results 1
Failing to educate patients: Patients with positive antibody but negative RNA should understand they are not currently infected but remain susceptible to reinfection 1
By following this evidence-based testing algorithm, clinicians can accurately diagnose HCV infection, enabling appropriate treatment decisions that reduce morbidity and mortality from chronic hepatitis C.